Alternatives to ImmunoScape
ImmunoScape is a Biotechnology tool: developing novel immunotherapies and diagnostics for cancer. Here are the 51 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to ImmunoScape
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
ImCheck TherapeuticsNot ratedImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
4D PathNot ratedPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Verve TherapeuticsNot ratedDeveloping gene editing therapies to lower cholesterol.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Showing the next 20 closest matches. See the rest on the ImmunoScape profile.
Sponsored rows are paid and labelled. Advertise on this page
